Sowell Financial Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,257
Closed -$1.32M 525
2023
Q2
$1.32M Buy
+10,257
New +$1.24M 0.07% 302
2021
Q2
Sell
-2,420
Closed -$216K 1102
2021
Q1
$216K Sell
2,420
-1,376
-36% -$129K 0.01% 1010
2020
Q4
$351K Sell
3,796
-912
-19% -$81.4K 0.02% 635
2020
Q3
$485K Buy
4,708
+240
+5% +$25.1K 0.02% 475
2020
Q2
$453K Buy
4,468
+2,776
+164% +$248K 0.02% 484
2020
Q1
$114K Sell
1,692
-416
-20% -$25.9K 0.01% 802
2019
Q4
$115K Buy
2,108
+908
+76% +$43.1K 0.01% 872
2019
Q3
$45K Buy
+1,200
New +$46.6K ﹤0.01% 1027

Other funds holding DXCM

Sowell Financial Services's DXCM Position: Q3 2023 in Review

Sowell Financial Services sold out of DexCom (DXCM) in Q3 2023, closing a stake of 10,257 shares — an estimated $1.32M sold.

Sowell Financial Services first reported a position in DXCM in Q3 2019 and held it in 8 quarters. The position peaked at $1.32M in Q2 2023. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

  • Sowell Financial Services reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
  • Sowell Financial Services sold 10,257 DexCom shares in Q3 2023, an estimated $1.32M.
  • Sowell Financial Services first reported a position in DexCom in Q3 2019 and held it in 8 quarters.
  • Sowell Financial Services's DexCom position peaked at $1.32M in Q2 2023.
  • 902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Sowell Financial Services's 13F filing for Q3 2023, filed 8 Nov 2023.